Healthcare provider profile · identity verified

Robert Lamar Cater, MD,AAFP

Family Practice · ANNISTON, AL · NPI 1053474452

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	285	103
Atorvastatin Calcium	Atorvastatin Calcium	237	84
Levothyroxine Sodium	Levothyroxine Sodium	185	59
Losartan Potassium	Losartan Potassium	142	52
Gabapentin	Gabapentin	128	36
Rosuvastatin Calcium	Rosuvastatin Calcium	123	38
Lisinopril	Lisinopril	120	41
Pantoprazole Sodium	Pantoprazole Sodium	115	45
Clonazepam	Clonazepam	113	22
Omeprazole	Omeprazole	111	41
Alprazolam	Alprazolam	106	20
Montelukast Sodium	Montelukast Sodium	103	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	101	25
Tramadol Hcl	Tramadol Hcl	101	29
Zolpidem Tartrate	Zolpidem Tartrate	98	16
Metformin Hcl	Metformin Hcl	94	39
Hydrochlorothiazide	Hydrochlorothiazide	92	35
Carvedilol	Carvedilol	87	27
Azithromycin	Azithromycin	86	82
Albuterol Sulfate Hfa	Albuterol Sulfate	80	31
Tizanidine Hcl	Tizanidine Hcl	77	21
Sertraline Hcl	Sertraline Hcl	76	24
Escitalopram Oxalate	Escitalopram Oxalate	71	20
Meloxicam	Meloxicam	69	32
Tamsulosin Hcl	Tamsulosin Hcl	59	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	21
Potassium Chloride	Potassium Chloride	58	20
Clopidogrel	Clopidogrel Bisulfate	57	20
Mounjaro	Tirzepatide	55	11
Metoprolol Succinate	Metoprolol Succinate	54	20
Duloxetine Hcl	Duloxetine Hcl	53	15
Fluticasone Propionate	Fluticasone Propionate	52	17
Glimepiride	Glimepiride	49	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	15
Furosemide	Furosemide	44	16
Trulicity	Dulaglutide	44	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	40	37
Lorazepam	Lorazepam	39	11
Metoprolol Tartrate	Metoprolol Tartrate	39	14
Ozempic	Semaglutide	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	39	12
Atenolol	Atenolol	38	14
Diazepam	Diazepam	38	suppressed
Prednisone	Prednisone	37	25
Alendronate Sodium	Alendronate Sodium	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	14
Allopurinol	Allopurinol	35	12
Simvastatin	Simvastatin	35	12
Trazodone Hcl	Trazodone Hcl	35	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	32
Levofloxacin	Levofloxacin	33	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Methocarbamol	Methocarbamol	31	15
Methylprednisolone	Methylprednisolone	30	27
Fenofibrate	Fenofibrate	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Valsartan	Valsartan	27	suppressed
Famotidine	Famotidine	26	13
Enalapril Maleate	Enalapril Maleate	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Glipizide	Glipizide	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Cefdinir	Cefdinir	19	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Levemir Flexpen	Insulin Detemir	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	13
Benazepril Hcl	Benazepril Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Eliquis	Apixaban	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Mupirocin	Mupirocin	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Digoxin	Digoxin	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	14
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Naproxen	Naproxen	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Valacyclovir	Valacyclovir Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error